Abraham Theodore P, Jones Michelle, Kazmierczak Katarzyna, Liang Hsin-Yueh, Pinheiro Aurelio C, Wagg Cory S, Lopaschuk Gary D, Szczesna-Cordary Danuta
Division of Cardiology, Johns Hopkins University, Baltimore, MD, USA.
Cardiovasc Res. 2009 Apr 1;82(1):84-92. doi: 10.1093/cvr/cvp016. Epub 2009 Jan 15.
Several mutations in the ventricular myosin regulatory light chain (RLC) were identified to cause familial hypertrophic cardiomyopathy (FHC). Based on our previous cellular findings showing delayed calcium transients in electrically stimulated intact papillary muscle fibres from transgenic Tg-R58Q and Tg-N47K mice and, in addition, prolonged force transients in Tg-R58Q fibres, we hypothesized that the malignant FHC phenotype associated with the R58Q mutation is most likely related to diastolic dysfunction.
Cardiac morphology and in vivo haemodynamics by echocardiography as well as cardiac function in isolated perfused working hearts were assessed in transgenic (Tg) mutant mice. The ATPase-pCa relationship was determined in myofibrils isolated from Tg mouse hearts. In addition, the effect of both mutations on RLC phosphorylation was examined in rapidly frozen ventricular samples from Tg mice. Significantly, decreased cardiac function was observed in isolated perfused working hearts from both Tg-R58Q and Tg-N47K mice. However, echocardiographic examination showed significant alterations in diastolic transmitral velocities and deceleration time only in Tg-R58Q myocardium. Likewise, changes in Ca(2+) sensitivity, cooperativity, and an elevated level of ATPase activity at low [Ca(2+)] were only observed in myofibrils from Tg-R58Q mice. In addition, the R58Q mutation and not the N47K led to reduced RLC phosphorylation in Tg ventricles.
Our results suggest that the N47K and R58Q mutations may act through similar mechanisms, leading to compensatory hypertrophy of the functionally compromised myocardium, but the malignant R58Q phenotype is most likely associated with more severe alterations in cardiac performance manifested as impaired relaxation and global diastolic dysfunction. At the molecular level, we suggest that by reducing the phosphorylation of RLC, the R58Q mutation decreases the kinetics of myosin cross-bridges, leading to an increased myofilament calcium sensitivity and to overall changes in intracellular Ca(2+) homeostasis.
已确定心室肌球蛋白调节轻链(RLC)中的几种突变可导致家族性肥厚型心肌病(FHC)。基于我们之前的细胞研究结果,显示转基因Tg-R58Q和Tg-N47K小鼠的完整乳头肌纤维在电刺激下钙瞬变延迟,此外,Tg-R58Q纤维中的力瞬变延长,我们推测与R58Q突变相关的恶性FHC表型很可能与舒张功能障碍有关。
对转基因(Tg)突变小鼠进行心脏形态学、超声心动图评估的体内血流动力学以及离体灌注工作心脏的心脏功能评估。测定了从Tg小鼠心脏分离的肌原纤维中的ATP酶-pCa关系。此外,在Tg小鼠快速冷冻的心室样本中检测了两种突变对RLC磷酸化的影响。值得注意的是,在Tg-R58Q和Tg-N47K小鼠的离体灌注工作心脏中均观察到心脏功能下降。然而,超声心动图检查仅在Tg-R58Q心肌中显示舒张期二尖瓣跨瓣速度和减速时间有显著改变。同样,仅在Tg-R58Q小鼠的肌原纤维中观察到Ca(2+)敏感性、协同性的变化以及低[Ca(2+)]时ATP酶活性水平升高。此外,R58Q突变而非N47K导致Tg心室中RLC磷酸化减少。
我们的结果表明,N47K和R58Q突变可能通过相似的机制起作用,导致功能受损心肌的代偿性肥厚,但恶性R58Q表型很可能与心脏性能更严重的改变有关,表现为舒张功能受损和整体舒张功能障碍。在分子水平上,我们认为R58Q突变通过减少RLC的磷酸化,降低了肌球蛋白横桥的动力学,导致肌丝钙敏感性增加以及细胞内Ca(2+)稳态的整体变化。